EBT-101 Phase 1/2 clinical trial (IMAGE)
Caption
The launch of the EBT-101 Phase 1/2 clinical trial was made possible by research led by (right) Kamel Khalili, PhD, Laura H. Carnell Professor and Chair of the Department of Microbiology, Immunology, and Inflammation; Director of the Center for Neurovirology and Gene Editing; and Director of the Comprehensive NeuroAIDS Center, and (left) Tricia H. Burdo, PhD, Professor and Vice Chair in the Department of Microbiology, Immunology, and Inflammation at the Lewis Katz School of Medicine at Temple University.
Credit
Ryan S. Brandenberg, Temple University
Usage Restrictions
This photo may only be used in reporting about the research referenced in the image title.
License
Original content